• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

患者纳入合作组临床试验。

Recruitment of patients to cooperative group clinical trials.

作者信息

Lee J Y, Marks J E, Simpson J R

出版信息

Cancer Clin Trials. 1980;3(4):381-4.

PMID:7428142
Abstract

One of the prerequisites for a successful clinical trial is the accrual of a sufficient number of patients for study. Because the sample-size requirements for a randomized clinical trial can rarely be met by a single institution in a short period of time, cooperative groups have taken in a major role in conducting clinical trials. In this paper, the recruitment of patients at our institution to a lung cancer clinical trial is evaluated. A total of 653 lung cancer cases were reviewed. Of the 77 cases which were eligible for the trial, 41 were accessioned. The reasons why eligible patients were not accessioned to the trial are discussed.

摘要

成功开展一项临床试验的前提条件之一是招募到足够数量的患者进行研究。由于单个机构在短时间内很少能满足随机临床试验的样本量要求,协作组在开展临床试验中发挥了主要作用。本文评估了我院将患者纳入一项肺癌临床试验的情况。共审查了653例肺癌病例。在符合试验条件的77例病例中,有41例被纳入。文中讨论了符合条件的患者未被纳入试验的原因。

相似文献

1
Recruitment of patients to cooperative group clinical trials.患者纳入合作组临床试验。
Cancer Clin Trials. 1980;3(4):381-4.
2
The impact of the physician on the accrual to randomized clinical trials in patients with primary operable breast cancer.医生对原发性可手术乳腺癌患者纳入随机临床试验的影响。
Breast. 2005 Aug;14(4):310-6. doi: 10.1016/j.breast.2005.01.004.
3
Addressing the current challenges of non-small-cell lung cancer clinical trial accrual.应对非小细胞肺癌临床试验入组的当前挑战。
Clin Lung Cancer. 2008 Jul;9(4):222-6. doi: 10.3816/CLC.2008.n.033.
4
Composite randomization designs for clinical trials.用于临床试验的复合随机化设计。
Biometrics. 1981 Dec;37(4):723-31.
5
Selection factors in clinical trials: results from the Community Clinical Oncology Program Physician's Patient Log.
Cancer Treat Rep. 1987 Jun;71(6):559-65.
6
Surgeons: A Future Role in Clinical Trials?外科医生:在临床试验中未来会扮演何种角色?
Oncologist. 1997;2(3):V-VI.
7
Improving accrual of older persons to cancer treatment trials: a randomized trial comparing an educational intervention with standard information: CALGB 360001.提高老年人参与癌症治疗试验的入组率:一项比较教育干预与标准信息的随机试验:CALGB 360001
J Clin Oncol. 2005 Apr 1;23(10):2201-7. doi: 10.1200/JCO.2005.01.222.
8
Computer-based screening of patients with HIV/AIDS for clinical-trial eligibility.基于计算机对艾滋病毒/艾滋病患者进行临床试验资格筛查。
Online J Curr Clin Trials. 1995 Mar 28;Doc No 179:[3347 words; 32 paragraphs].
9
A single mathematical model predicts physicians' recommendations and postmenopausal women's decisions to participate in a clinical trial to prevent breast cancer or coronary heart disease.
Med Decis Making. 2004 Jul-Aug;24(4):330-50. doi: 10.1177/0272989X04267007.
10
A report on accrual rates for elderly and minority-ethnicity cancer patients to clinical trials of the American College of Surgeons Oncology Group.美国外科医师学会肿瘤学组针对老年和少数族裔癌症患者参与临床试验的入组率报告。
J Am Coll Surg. 2004 Oct;199(4):644-51. doi: 10.1016/j.jamcollsurg.2004.05.282.

引用本文的文献

1
Barriers and facilitators to the participation of subjects in clinical trials: An overview of reviews.受试者参与临床试验的障碍与促进因素:综述概述
Contemp Clin Trials Commun. 2021 Aug 3;23:100829. doi: 10.1016/j.conctc.2021.100829. eCollection 2021 Sep.
2
Competing commitments in clinical trials.临床试验中的相互冲突的任务。
IRB. 2009 Sep-Oct;31(5):1-6.
3
Incentives and disincentives to participation by clinicians in randomised controlled trials.临床医生参与随机对照试验的激励因素和阻碍因素。
Cochrane Database Syst Rev. 2007 Apr 18;2007(2):MR000021. doi: 10.1002/14651858.MR000021.pub3.
4
Are racial and ethnic minorities less willing to participate in health research?少数族裔参与健康研究的意愿较低吗?
PLoS Med. 2006 Feb;3(2):e19. doi: 10.1371/journal.pmed.0030019. Epub 2005 Dec 6.
5
Attitude of African-Americans regarding prostate cancer clinical trials.非裔美国人对前列腺癌临床试验的态度。
J Community Health. 1996 Apr;21(2):77-87. doi: 10.1007/BF01682300.
6
Designing clinical protocols for optimal use: measuring attributes of treatment and cancer control trials.
J Med Syst. 1991 Dec;15(5-6):335-44. doi: 10.1007/BF00995972.